Bill Adams steps in as CFO of Response Biomedical

By Admin
Share
Response Biomedical Corporation said its board of directors has appointed Mr. Bill Adams as Chief Financial Officer and Corporate Secretary with effect...

Response Biomedical Corporation said its board of directors has appointed Mr. Bill Adams as Chief Financial Officer and Corporate Secretary with effect from August 13, 2012.

The newly appointed CFO and Corporate Secretary will replace Richard Canote. Mr. Canote resigned as the CFO of Response Biomedical but will continue with the company for a certain duration in a consulting capacity.  

“We welcome the addition of Bill to the Response management team. Bill’s experience and expertise will allow the company to continue to focus on its stated corporate objective of profitable growth,” said, Mr. Jeffrey Purvin, CEO. He adds, “We thank Rich Canote for his assistance this year in the transaction process.”  

Mr. Adams is a Chartered Accountant with more than 20 years of strategic financial management experience in both private and public companies. He was also the CFO for CellFor Inc. CellFor Inc is engaged in manufacturing of tree seedings for forest land owners.

He also held a similar position in a publicly-listed bio-pharmaceutical company AnorMED  Inc from its start up through its sale to a U.S-based international bio-pharmaceutical company.  

Prior to being part of AnorMED, Mr. Bill was the Chief Financial Officer of  a TSX- listed technology company namely Epic Data International Inc.  He has also been an audit manager with KPMG. 

Mr. Bill holds a Bachelors degree in Commerce from the University of British Columbia. 

Response Biomedical is involved in developing, manufacturing and marketing of rapid on-site diagnostic tests for use with its RAMP (R) platform for environmental and clinical applications.

Share

Featured Articles

How Huawei's Digital Solutions are Transforming Healthcare

Offering network, cloud, and AI solutions, Huawei is able to help healthcare providers deliver better outcomes for patients

2024 Nestlé Nutrition Symposium Explored Food & Health

Nestlé manufactures 4.5m KitKats every day, but the food giant is also focused on advancing food nutrition, as explored at the 2024 International Symposium

Thirona’s AI Tech is Creating Individualised Patient Care

Eva van Rikxoort, CEO and Founder of Thirona, tells us how AI technology is advancing lung imaging and bringing more individualised treatment to patients

AstraZeneca’s Discovery Centre, Constructed by Mace Group

Technology & AI

NeoGenomics: Data in Oncology Testing & Diagnostics

AI & ML

Samsung’s New Health Software Development Kit Suite

Digital Healthcare